Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cytokinetics (NQ: CYTK )

34.86 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 34.86
Bid (Size) 30.00 (3)
Ask (Size) 55.77 (2)
Prev. Close 34.86
Today's Range 34.86 - 34.86
52wk Range 25.98 - 47.49
Shares Outstanding 95,640,600
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Expert Ratings for Cytokinetics
Via Benzinga
Potential Takeover In Works for Cardiovascular Treatment Focused Cytokinetics
Cytokinetics Inc (NASDAQ: CYTK), a late-stage biotech company focused on cardiovascular treatments, is reportedly exploring potential takeover options as it has garnered interest from at least one... 
Via Benzinga

Performance

YTD
-21.40%
-21.40%
1 Month
-2.76%
-2.76%
3 Month
-4.78%
-4.78%
6 Month
-1.64%
-1.64%
1 Year
-5.89%
-5.89%

More News

Read More
HC Wainwright & Co. Maintains Buy Rating for Cytokinetics: Here's What You Need To Know
Via Benzinga
Union Pacific To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Expert Ratings for Cytokinetics
Via Benzinga
Where Cytokinetics Stands With Analysts
Via Benzinga
Where Cytokinetics Stands With Analysts
Via Benzinga
Why CalAmp Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
NuScale Power, Stagwell And Other Big Stocks Moving Higher On Friday
Via Benzinga
Topics Stocks
Exposures US Equities
11 Analysts Have This to Say About Cytokinetics
Via Benzinga
What 20 Analyst Ratings Have To Say About Cytokinetics
Via Benzinga
18 Analysts Have This to Say About Cytokinetics
Via Benzinga
Cytokinetics: Q1 Earnings Insights
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
The 3 Best Mid-Cap Stocks to Buy Now: September 2023
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023
Via Benzinga
Analyst Ratings for Cytokinetics
Via Benzinga
Analyst Expectations for Cytokinetics's Future
Via Benzinga
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
Via Benzinga
5 Biotech Stocks That Could Soar Thanks To These Disruptive Healthcare Technologies
Via Benzinga
Cytokinetics Plans To Discontinue Late-Stage ALS Trial Due To Futility
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.